Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts

Abstract

The cardiomyocyte undergoes dramatic changes in structure, metabolism, and function from the early fetal stage of hyperplastic cell growth, through birth and the conversion to hypertrophic cell growth, continuing to the adult stage and responding to various forms of stress on the myocardium, often leading to myocardial failure. The fetal cell with incompletely formed sarcomeres and other cellular and extracellular components is actively undergoing mitosis, organelle dispersion, and formation of daughter cells. In the first few days of neonatal life, the heart is able to repair fully from injury, but not after conversion to hypertrophic growth. Structural and metabolic changes occur following conversion to hypertrophic growth which forms a barrier to further cardiomyocyte division, though interstitial components continue dividing to keep pace with cardiac growth. Both intra- and extracellular structural changes occur in the stressed myocardium which together with hemodynamic alterations lead to metabolic and functional alterations of myocardial failure. This review probes some of the questions regarding conditions that regulate normal and pathologic growth of the heart.

Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs

“…Consistent with the animal studies, human in vitro models of high glucose injury showed that both podocytes and cardiomyocytes exhibited a significant increase in average surface area after high glucose injury, whereas T3 reversed this response ( Figures 3 G and 3H). Cultured cardiomyocytes stressed with high glucose concentration not only had a larger cell area but also adopted a “fetal-like” round shape 28 , 29 which was normalized by T3 treatment ( Figure 3 I).…”

Effect of Postnatal Epigallocatechin-Gallate Treatment on Cardiac Function in Mice Prenatally Exposed to Alcohol

“…Troponin I regulates the state of thin and thick filaments in the sarcomere [63], inhibiting muscle contraction in the absence of calcium. The slow skeletal muscle cardiac troponin I isoform is predominant in the developing fetal heart, replaced by the mature sarcomere cardiac isoform at around birth [64]. In congenital heart defects, there is a delay in the expression of the latter isoform [65].…”

Proliferation and Maturation: Janus and the Art of Cardiac Tissue Engineering

“…At early developmental stages, when cardiomyocytes are proliferative, cardiomyocytes contain fewer and less-organized sarcomeres. 4,13,14 During cardiomyocyte maturation, new sarcomeres are added to the preexisting myofibrillar network, and collectively, sarcomeres undergo structural changes as adult isoforms of sarcomeric proteins replace the fetal isoforms. For example, mammalian cardiac MHC (myosin heavy chain) proteins have 2 isoforms, α-isoform ( MYH6 ) and β-isoform ( MYH7 ), encoded by 2 distinct genes.…”